General Info
The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
Location: 106 Allen Road, Bernards, New Jersey, United States, 07920
Country: United States of America
Industries: Healthcare,Medical Device,Manufacturing
Investment Regions: EU, NA
Investment Stages: seed, series-a
Website: http://www.vertical-group.com
vc
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Search of The Vertical Group’s website and public profiles shows the most recent dated investment references are from 2013 (SingularBIO) and several from 2010-2014 (TetraLogic, Silk Road Medical, Meritage). No investments or portfolio updates with dates within the past 12 months or within the last 6-3 months were found. The last clearly dated investment found is 2013 (SingularBIO), which is more than 12 months ago (over a decade). Therefore the investor is classified as not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Jack …
General Partner
John …
General Partner
Tony …
General Partner
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of The Vertical Group
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI